Infertility Treatment Market Size to reach USD 3.10 Billion in 2030 - Emergen Research

The infertility treatment market is growing rapidly due to the rising incidence of infertility cases across the globe. Infertility is a widespread problem affecting both men and women, with an estimated 48.5 million couples experiencing infertility globally The global infertility treatment market size was USD 1.53 Billion in 2021 and is expected to register a steady revenue CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research.
One of the major drivers of the infertility treatment market is the increasing age of parenthood. The average age of first-time mothers has been rising steadily over the past few decades, with many women delaying childbirth due to personal and professional reasons. Older women have a higher risk of infertility, and this has led to an increase in demand for infertility treatment options such as in vitro fertilization (IVF) and other assisted reproductive technologies (ART).

Another factor driving the growth of the infertility treatment market is the increasing prevalence of lifestyle disorders such as obesity, diabetes, and hypertension. These conditions can affect fertility and increase the risk of infertility, leading to a higher demand for infertility treatments. According to the World Health Organization (WHO), the global prevalence of diabetes has nearly doubled since 1980, and this trend is expected to continue in the coming years.

However, the high cost of infertility treatment is a major factor restraining market growth. Infertility treatment can be expensive, and many couples may not be able to afford the cost of treatment. In addition, infertility treatment is often not covered by health insurance, further adding to the financial burden for couples seeking treatment.

Nevertheless, there are several growth opportunities in the infertility treatment market. Technological advancements in assisted reproductive technologies have led to the development of new and innovative treatment options. For example, the use of time-lapse imaging technology in IVF has been shown to improve embryo selection and increase the success rate of IVF procedures. Similarly, the use of genetic screening and testing techniques has led to improved diagnosis and treatment options for infertility.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1841

Government organizations have also recognized the need for increased support for infertility treatment. For example, in the U.S., the Centers for Disease Control and Prevention (CDC) provides funding for infertility treatment and research through the National Infertility Prevention Project. In addition, the Affordable Care Act requires insurance plans to cover certain infertility treatments, including diagnosis and treatment of underlying medical conditions that cause infertility.

Major Companies and Competitive Landscape:

The global infertility treatment market is highly competitive, with several major players competing for market share. Some of the key players in the market include Ferring B.V., Merck & Co., Inc., Bayer AG, Abbott, Sumitomo Pharma Co., Ltd., Livzon, Zydus Group, Oxolife, Bio-Rad Laboratories, Inc., and Mankind Pharma. These companies are actively involved in product development and innovation to stay ahead of the competition. For example, in 2021, Merck & Co., Inc. launched a new fertility treatment product, Pergoveris, which is designed to stimulate egg development in women undergoing assisted reproductive technologies (ART).

In addition to product development, many of these companies are also focused on strategic partnerships and acquisitions to expand their market reach. For example, in 2020, CooperSurgical, Inc. acquired The Pipette Company, a UK-based manufacturer of laboratory consumables. This acquisition was aimed at expanding CooperSurgical's product portfolio in the IVF and fertility space.

Another key trend in the infertility treatment market is the increasing focus on patient-centric care. Companies are investing in patient education and support services to help patients navigate the complex and often emotional journey of infertility treatment. For example, Boston IVF offers a range of support services, including a fertility coach program and online support groups, to help patients through their treatment journey.

In terms of regional market share, North America and Europe are currently the largest markets for infertility treatment, due to factors such as advanced healthcare infrastructure, high disposable income, and increasing awareness about fertility treatment options. However, the Asia Pacific region is expected to witness significant growth during the forecast period, driven by factors such as increasing healthcare spending, a large population base, and rising awareness about infertility treatment options.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1841

Segmentation Insights for Infertility Treatment Market Report:

The global infertility treatment market has been segmented by Emergen Research on the basis of product, procedure, patient type, end-use, and region. By product, the market has been segmented into microscopes, media and consumables, and accessories. The assisted reproductive technology segment dominates the procedure outlook segment, followed by artificial insemination and fertility surgeries. The patient type segment has been further categorized into female infertility treatment and male infertility treatment. The end-use segment includes fertility centers, hospitals and surgical clinics, cryobanks, and other end-use facilities.

Geographically, the North American region, including the United States, Canada, and Mexico, holds the largest share of the global infertility treatment market due to factors such as high disposable income, advanced healthcare infrastructure, and increasing awareness about fertility treatment options. The European region, including countries such as Germany, France, the UK, Italy, Spain, and Benelux, is also a significant market for infertility treatment. The Asia Pacific region is expected to witness significant growth during the forecast period due to factors such as increasing healthcare spending, a large population base, and rising awareness about infertility treatment options. The Latin America and Middle East & Africa regions are also expected to witness significant growth during the forecast period.

The infertility treatment market is driven by several factors such as increasing age of parenthood, rising prevalence of lifestyle disorders, and technological advancements in assisted reproductive technologies. The market is highly competitive, with several major players competing for market share. Some of the key players in the market include CooperSurgical, Inc., Vitrolife AB, Ferring Pharmaceuticals, Inc., Irvine Scientific, OvaScience, Inc., Boston IVF, and Monash IVF Group. Companies are investing in product development and innovation, strategic partnerships and acquisitions, and patient-centric care to stay ahead of the competition in this highly competitive market.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/infertility-treatment-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.